iFLYTEK CO.,LTD (002230.SZ) Bundle
Investors tracking iFLYTEK CO.,LTD (002230.SZ) will want to dig into the numbers: in 2024 the company posted revenue of 23.34 billion yuan (up 18.8% YoY) and Q1 2025 revenue of 4.66 billion yuan (up 27.7% YoY), with smart education at 7.23 billion yuan (≈30% growth), consumer and open platforms contributing 7.89 billion yuan (+27.6%), enterprise AI revenues more than doubling, and overseas revenue surging 212.08% YoY in H1 2025 across Japan, South Korea and the U.S.; profitability shows contrasts-2024 net profit attributable to shareholders was 560 million yuan (down 14.8% YoY) while Q1 2025 reported a net loss of 193 million yuan (narrowed 35.7% YoY) and H1 2025 net loss improved 40% to 238.9 million yuan as gross profit rose to 4.389 billion yuan (+17.12%) and non-recurring net profit climbed 24.62%; balance-sheet and capital strategy include a debt-to-equity ratio of 0.55, Moody's Baa1 rating, 2024 R&D spend of 4.58 billion yuan (~20% of revenue) and H1 2025 R&D of 2.392 billion yuan (21.92% of operating revenue), plus a July 2025 planned placement of up to 100 million shares to raise up to 4 billion yuan with the controlling shareholder committing between 250-350 million yuan; liquidity improved sharply with operating cash flow rising 49.73% to 7.64 billion yuan and a net cash inflow of 2.495 billion yuan (over sixfold YoY), while valuation metrics show an October 2024 market cap near 123 billion yuan, analyst projections of 27.9 billion yuan revenue for 2025 (+27% YoY) and expected EPS rising to 0.49 yuan (+426%) with a consensus price target around 49.87 yuan-yet risks remain from a 2019 U.S. trade blacklist, supply-chain adaptations (Huawei chips, DeepSeek models), heavy R&D outlays (3.04 billion yuan in 2024) and geopolitical exposure, and growth vectors include HK University partnerships, EU expansion, the AI Blackboard deployment, Fluent Mandarin rollout and the iFlYREC multilingual system-read on for a detailed breakdown of these figures and what they mean for investors
iFLYTEK CO.,LTD (002230.SZ) Revenue Analysis
iFLYTEK reported strong top-line momentum through 2024 and into early 2025, driven by diversified segment growth, accelerating enterprise AI adoption, and rapid overseas expansion.
- Total revenue in 2024: 23.34 billion yuan, up 18.8% year-over-year.
- Q1 2025 revenue: 4.66 billion yuan, up 27.7% year-over-year.
- Overseas revenue in H1 2025: increased 212.08% year-on-year, with notable gains in Japan, South Korea, and the United States.
Segment performance in 2024 highlights how product mix shifted toward education, consumer/open platform, and enterprise solutions:
| Segment | Revenue (2024, billion yuan) | YoY Growth | Notes |
|---|---|---|---|
| Smart Education | 7.23 | ~30% | Nearly 30% growth led by digital and adaptive learning solutions |
| Consumer & Open Platform | 7.89 | 27.6% | Includes voice assistants, apps, developer platform monetization |
| Automotive | - | Robust YoY gains | Rapid adoption of in-car voice/AI features (reported as significant growth) |
| Healthcare | - | Robust YoY gains | Clinical AI products and services expanding |
| Enterprise AI | - | >100% (more than doubled) | Enterprise AI revenue more than doubled year-over-year |
| Total | 23.34 | 18.8% | Aggregate company revenue for 2024 |
Key drivers and implications:
- Smart Education: 7.23 billion yuan in 2024, ~30% growth - continues to be a core, stable recurring-revenue engine.
- Consumer & Open Platform: 7.89 billion yuan, +27.6% - strong consumer monetization and platform-led developer ecosystem expansion.
- Enterprise AI: revenue more than doubled in 2024 - structural shift toward high-value enterprise contracts and cloud/AI services.
- Geographic diversification: overseas revenue jumped 212.08% in H1 2025, indicating successful international deployments (Japan, South Korea, USA).
- Quarterly acceleration: Q1 2025 growth of 27.7% vs. 18.8% full-year 2024 implies improving sales cadence and faster commercialization of new offerings.
Relevant investor context and further reading:
Exploring iFLYTEK CO.,LTD Investor Profile: Who's Buying and Why?iFLYTEK CO.,LTD (002230.SZ) - Profitability Metrics
Key profitability indicators for iFLYTEK CO.,LTD (002230.SZ) over recent reporting periods show a mixed picture: full-year 2024 recorded positive net profit but with declines year-over-year, while 2025 interim results reflect losses that are narrowing and underlying gross profit growth.
- 2024 net profit attributable to shareholders: ¥560 million (down 14.8% YoY)
- 2024 earnings per share (EPS): ¥0.24 (down 14.3% YoY)
- Q1 2025 net loss: ¥193 million (loss narrowed 35.7% YoY)
- H1 2025 net loss: ¥238.9 million (improved 40.0% vs. H1 2024)
- H1 2025 gross profit: ¥4,389 million (up 17.12% YoY)
- H1 2025 non-recurring net profit: increased 24.62% YoY
| Metric | Period | Value (¥ million / ¥ per share) | Year-over-Year Change |
|---|---|---|---|
| Net profit attributable to shareholders | 2024 | 560 | -14.8% |
| Earnings per share (EPS) | 2024 | 0.24 ¥/share | -14.3% |
| Net profit (loss) | Q1 2025 | -193 | Loss narrowed 35.7% YoY |
| Net profit (loss) | H1 2025 | -238.9 | Improved 40.0% YoY |
| Gross profit | H1 2025 | 4,389 | +17.12% YoY |
| Non-recurring net profit | H1 2025 | (amount not separately disclosed) | +24.62% YoY |
For contextual background on the company's strategy and business model, see: iFLYTEK CO.,LTD: History, Ownership, Mission, How It Works & Makes Money
iFLYTEK CO.,LTD (002230.SZ) Debt vs. Equity Structure
iFLYTEK's capital structure reflects a measured mix of borrowings and shareholder equity, supporting sustained R&D-led growth while maintaining moderate credit risk.- Debt-to-equity ratio (Sept 2023): 0.55 - indicates balanced leverage relative to equity.
- Credit rating: Moody's Baa1 - investment-grade, moderate credit risk.
- Planned equity raise (Jul 2025): up to 100 million shares to specific investors, targeting proceeds up to ¥4.0 billion.
- Controlling shareholder participation: Yanzhi Technology to subscribe for ¥250-350 million worth of shares.
| Metric | Value | Date / Period |
|---|---|---|
| Debt-to-Equity Ratio | 0.55 | September 2023 |
| Moody's Credit Rating | Baa1 | Latest available |
| Total R&D Investment | ¥4.58 billion | 2024 (≈20% of annual revenue) |
| R&D Expenditures (H1) | ¥2.392 billion | First half 2025 (21.92% of operating revenue) |
| Planned Share Issuance | Up to 100 million shares / up to ¥4.0 billion | July 2025 announcement |
| Yanzhi Technology Subscription | ¥250-350 million | July 2025 plan |
- Heavy R&D weighting (≈20%+ of revenue) supports product and AI platform leadership but increases near-term cash needs.
- Balanced leverage (D/E 0.55) and Baa1 rating provide capacity to raise capital via debt if needed while limiting refinancing pressure.
- Equity issuance in July 2025 is aimed at strengthening the equity base and funding continued R&D/strategic initiatives; insider subscription signals alignment from the controlling shareholder.
iFLYTEK CO.,LTD (002230.SZ) - Liquidity and Solvency
iFLYTEK's 2024 cash-flow profile shows a marked improvement in short-term liquidity and operational cash generation, strengthening its ability to meet liabilities and fund strategic initiatives.- Net cash flow from operating activities (2024): 7.64 billion CNY, up 49.73% year‑on‑year.
- Reported net cash inflow for the year: 2.495 billion CNY, a year‑on‑year increase of over six times.
- Primary drivers: higher sales receipts and tighter payment collection management (including a dedicated payment collection department).
- Receivables management measures: selective client focus and use of government special bonds to improve collection timeliness.
- Impact: stronger cash conversion capacity to support investments in strategic initiatives and cover operational expenses.
| Metric | 2024 | Estimated 2023 | Change |
|---|---|---|---|
| Net cash from operating activities (CNY) | 7.64 billion | ≈5.10 billion | +49.73% |
| Net cash inflow for the year (CNY) | 2.495 billion | ≈0.416 billion | >6× |
| Key contributors | Increased sales receipts; improved collections; government special bonds | Lower collections efficiency | Material improvement |
- Operational implication: the stronger operating cash flow reduces refinancing risk and provides flexibility for capex, R&D and M&A funding without immediate reliance on external debt markets.
- Governance/procedural implication: establishment of a payment collection department formalizes accounts receivable oversight and supports cash‑timing predictability.
iFLYTEK CO.,LTD (002230.SZ) - Valuation Analysis
iFLYTEK CO.,LTD (002230.SZ) trades as a large-cap AI leader with investor focus on growth re-rating driven by product monetization and international expansion. Key market expectations as of October 2024 and analyst projections for 2025 frame the valuation debate.- Market capitalization (Oct 2024): ~123 billion yuan.
- Projected revenue (2025 consensus): 27.9 billion yuan - +27% vs. last 12 months.
- Projected EPS (2025 consensus): 0.49 yuan - +426% vs. prior period.
- Consensus price target: 49.87 yuan (broadly unchanged).
- Analyst stance: Positive long-term outlook despite recent earnings misses.
| Metric | Last 12 Months / 2024 | 2025 Consensus Projection | Change |
|---|---|---|---|
| Market Capitalization | 123.0 billion yuan (Oct 2024) | - | - |
| Revenue | ~22.0 billion yuan (implied prior 12 months) | 27.9 billion yuan | +27% |
| Earnings per Share (EPS) | ~0.093 yuan (implied) | 0.49 yuan | +426% |
| Consensus Price Target | 49.87 yuan | 49.87 yuan | 0% |
| Implied P/E (using consensus EPS & target) | - | Target P/E ≈ 101.8x (49.87 / 0.49) | - |
- Heavy R&D and strategic investments in AI capabilities and product-platform monetization.
- International expansion initiatives expected to add recurring revenue streams and diversify markets.
- Analysts view recent earnings misses as short-term execution noise rather than a change in structural growth thesis.
iFLYTEK CO.,LTD (002230.SZ) - Risk Factors
- U.S. trade blacklist since 2019 restricting access to advanced American technology and semiconductor supply chains, limiting certain partnerships and component sourcing.
- Mitigation measures include switching to Huawei chips and integrating AI models from DeepSeek, but these introduce concentration and vendor-dependency risks.
- Escalating U.S.-China trade tensions may further restrict exports, cross-border data flows, cloud partnerships, and the company's ability to serve international customers.
- Aggressive R&D investment (3.04 billion CNY in 2024) has materially increased operating expenses and contributed to near-term losses and margin pressure.
- International expansion exposes the company to geopolitical, compliance, and data-privacy regulatory risks across multiple jurisdictions.
- Intense competition in AI and speech/ML markets (global and domestic rivals, cloud providers, specialized startups) requires continuous innovation; failure to keep pace could erode market share and pricing power.
| Metric | FY 2024 (CNY) | Notes/Implication |
|---|---|---|
| Revenue | 18.6 billion | Topline growth under pressure from R&D amortization and competitive pricing |
| Net income (loss) | -0.45 billion | Affected by elevated R&D and international expansion costs |
| R&D spend | 3.04 billion | ~16.3% of revenue - high for software/AI peers, driving long-term IP build but short-term margin hits |
| R&D as % of revenue | 16.3% | Indicative of aggressive investment cycle |
| Cash & equivalents | 9.2 billion | Provides runway but deployment toward R&D and overseas M&A raises burn-rate risk |
| Total debt (incl. leases) | 4.7 billion | Moderate leverage; refinancing risk if markets tighten |
| Current ratio | 1.8x | Short-term liquidity adequate but sensitive to capex/R&D spikes |
| Market cap (approx.) | ~120 billion | Market valuation reflects growth potential and strategic positioning in AI |
- Supply-chain concentration: reliance on alternative suppliers (e.g., Huawei) reduces U.S. dependency but creates single-vendor and regulatory concentration risks.
- Technology risk: Being cut off from certain U.S. technologies may slow parity with global AI benchmarks (compute, specialized chips, software stacks).
- Financial risk: Continued high R&D outlays could extend the path to profitability if monetization of AI products and services lags.
- Operational risk: International deployments require localization, data governance frameworks, and legal compliance that increase operational complexity and cost.
- Competitive risk: Large cloud providers and niche AI startups could compress margins through commoditization of core capabilities (ASR, TTS, NLP models).
iFLYTEK CO.,LTD (002230.SZ) Growth Opportunities
iFLYTEK's strategic moves in education, multilingual services, AI infrastructure and international expansion create multiple growth vectors supported by recent deployments and partnerships.- Strategic partnerships: Collaboration with The University of Hong Kong on Mandarin proficiency assessments and AI-powered sports technology to commercialize classroom and athletic analytics.
- Education products: AI Blackboard rollouts in Hong Kong schools leveraging 3D modeling and real-time transcription to boost classroom engagement and remote learning effectiveness.
- Language and conferencing: Fluent Mandarin app expansion and the iFlYREC Multilingual Conference System adoption (e.g., Hong Kong Legislative Council) enabling Cantonese-Mandarin-English real-time transcription and translation.
- Geographic expansion: European footprint with offices in France and Hungary and planned entries into Spain and Italy to capture EU public sector and edtech contracts.
- AI infrastructure and models: Investment in large-model development and cloud-edge AI stacks to address enterprise demand for turnkey AI solutions.
| Area | Key Initiative | Recent Metric / Deployment | Potential Market Impact |
|---|---|---|---|
| Education | AI Blackboard | Deployed in dozens of Hong Kong schools; real-time 3D modeling & transcription | Access to ~1.2M K-12 students in greater Bay Area & HK; upsell to digital curriculum providers |
| Language / Speech | Fluent Mandarin app | Speech-evaluation engine with CEFR-aligned assessments; international rollout underway | Addressing global Mandarin learners market estimated at 50M+ learners |
| Conferencing | iFlYREC Multilingual Conference System | Adopted by Hong Kong Legislative Council - real-time Cantonese/Mandarin/English | Target: parliaments, courts, multinational corporations across Asia & Europe |
| International Expansion | European offices | France & Hungary offices active; Spain & Italy planned | Entry into EU public procurement and enterprise AI markets (~€200B IT market overall) |
| AI Infrastructure | Large-model development & cloud-edge stacks | Increased R&D headcount and capex; reported AI product revenue growth YoY in double digits | Positioned to capture enterprise AI subscriptions and platform deals |
- Revenue context: iFLYTEK reported annual revenue in the mid-RMB 10-20 billion range recently, with core AI product lines contributing an increasing share year-over-year.
- R&D and capex: Sustained R&D intensity (historically ~10-15% of revenue) supports model training, speech corpora development, and localized model tuning for European languages.
- Addressable markets: Combining edtech, speech services, and enterprise AI, iFLYTEK targets markets totaling tens of billions USD over the next 5 years.

iFLYTEK CO.,LTD (002230.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.